NIH will eliminate paylines in 2026, shifting grant funding decisions toward mission alignment, public health priorities, and programmatic judgment. Researchers now face greater uncertainty but also new opportunities under a more holistic and strategy-driven review process.
SBIR and STTR programs lapsed on Sept. 30, 2025, halting new awards. Agencies await reauthorization, likely via the FY2026 NDAA. Here’s where things stand and what’s next for small tech firms.
A small federal program with a $22-to-$1 return is at risk. Discover how SBIR quietly fueled America’s innovation engine—and why its future now hangs in the balance.
SBIR began as a U.S. experiment. Now it’s a global model for startup innovation, adopted by over 17 countries. Discover how the program reshaped R&D worldwide.
A NASA algae experiment led to a biotech breakthrough now nourishing 50 million babies. See how SBIR funding helped Martek reshape infant nutrition worldwide.
A lifesaving sensor system born in Air Force hangars is now protecting firefighters, crowds, and disaster zones—thanks to SBIR funding and public safety innovation.
A young startup backed by SBIR grants has built a machine that destroys toxic PFAS chemicals—once thought indestructible. It’s a game-changer for clean water.
A $1.5M SBIR grant helped Qualcomm invent mobile tech that powers your smartphone. See how early public funding launched a $174B telecom titan.
New research confirms it: SBIR grants don’t replace venture capital—they attract it. Startups with SBIR funding raise more VC money and reach bigger exits.
Genzyme’s $62K SBIR grant became a $20.1B success story. Learn how this biotech startup turned rare disease research into one of the biggest pharma deals ever.